All four D50 codes are active for services October 1, 2025 through September 30, 2026 under the FY2026 ICD-10-CM April 1, 2026 release
Tier Product description Product Specifications Active Compound: Retatrutide peptide Strength: 30mg per vial Form: Lyophilized powder Reconstitution Required: Yes, according to a validated laboratory protocol Manufacturer, as listed: Novera Compounds Country of Origin, as listed: United States Brand: Novera Intended Use: Laboratory and in vitro research only Package Content: 1 x 30mg vial Weight: 7 grams Dimensions: Width: 20mm | Height: 40mm | Length: 20mm Human-Use Status: Not approved for human use, clinical application, injection, or consumption What Is Retatrutide 30mg
I am very happy with this product Very simple process
Inject the solvent gently against the inner glass wall, rotating the vial to achieve complete dissolution without violent agitation
Pros: fastest visit, lowest cost per session, easy to book on a tight calendar
During your consultation, be prepared to discuss your medical history, current medications, and any known allergies
